Cargando…

PET-Based Volumetric Biomarkers for Risk Stratification of Non-Small Cell Lung Cancer Patients

Despite the recent advances in lung cancer biology, molecular pathology, and treatment, this malignancy remains the leading cause of cancer-related death worldwide and non-small cell lung cancer (NSCLC) is the most common form found at diagnosis. Accurate staging of the disease is a fundamental prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellegrino, Sara, Fonti, Rosa, Pulcrano, Alessandro, Del Vecchio, Silvana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911597/ https://www.ncbi.nlm.nih.gov/pubmed/33573333 http://dx.doi.org/10.3390/diagnostics11020210

Ejemplares similares

Heterogeneity of Glycolytic Phenotype Determined by (18)F-FDG PET/CT Using Coefficient of Variation in Patients with Advanced Non-Small Cell Lung Cancer
por: Pellegrino, Sara, et al.
Publicado: (2023)

Brain Metastases Unresponsive to Immunotherapy Detected by 18F-FDG-PET/CT in a Patient with Melanoma
por: Fonti, Rosa, et al.
Publicado: (2020)

Evaluation of metabolic response with (18)F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors
por: Segreto, Sabrina, et al.
Publicado: (2017)

Early (18)F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors
por: De Rosa, Viviana, et al.
Publicado: (2016)

Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy
por: De Rosa, Viviana, et al.
Publicado: (2021)

What molecular imaging of cancer patients can teach us about COVID-19
por: Del Vecchio, Silvana, et al.
Publicado: (2022)

A Reversible Shift of Driver Dependence from EGFR to Notch1 in Non-Small Cell Lung Cancer as a Cause of Resistance to Tyrosine Kinase Inhibitors
por: Iommelli, Francesca, et al.
Publicado: (2021)

Tumor heterogeneity in gastrointestinal stromal tumors of the small bowel: volumetric CT texture analysis as a potential biomarker for risk stratification
por: Feng, Cui, et al.
Publicado: (2018)

Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
por: Piscopo, Leandra, et al.
Publicado: (2023)

Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells
por: De Rosa, Viviana, et al.
Publicado: (2019)

Risk Stratification in Lung Resection
por: Salati, Michele, et al.
Publicado: (2016)

Non-Canonical Role of PDK1 as a Negative Regulator of Apoptosis through Macromolecular Complexes Assembly at the ER–Mitochondria Interface in Oncogene-Driven NSCLC
por: De Rosa, Viviana, et al.
Publicado: (2021)

Influencing Factors and Prognostic Value of (18)F-FDG PET/CT Metabolic and Volumetric Parameters in Non-Small Cell Lung Cancer
por: Zhang, Lixia, et al.
Publicado: (2021)

Metabolic Volumetric Parameters in (11)C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer
por: Tseng, Jing-Ren, et al.
Publicado: (2018)

Volumetric stratification of cT4 stage head and neck cancer
por: Studer, G., et al.
Publicado: (2013)

Volumetric Flow Assessment in Doppler Ultrasonography in Risk Stratification of Patients with Internal Carotid Stenosis and Occlusion
por: Kaszczewski, Piotr, et al.
Publicado: (2022)

Biomarkers for risk stratification and antibiotic stewardship in elderly patients
por: Falcone, Marco, et al.
Publicado: (2023)

An exploratory study of volumetric analysis for assessing tumor response with (18)F-FAZA PET/CT in patients with advanced non-small-cell lung cancer (NSCLC)
por: Kerner, Gerald S. M. A., et al.
Publicado: (2016)

Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
por: Guberina, Maja, et al.
Publicado: (2021)

Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer
por: Semenkovich, Nicholas P., et al.
Publicado: (2023)

Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer
por: Semenkovich, Nicholas P., et al.
Publicado: (2023)

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer
por: Pellini, Bruna, et al.
Publicado: (2023)

Comparison of volumetric and functional parameters in simultaneous cardiac PET/MR: feasibility of volumetric assessment with residual activity from prior PET/CT
por: Lücke, C., et al.
Publicado: (2017)

Biomarker-Based Preoperative Risk Stratification for Patients Undergoing Non-Cardiac Surgery
por: Yurttas, Timur, et al.
Publicado: (2020)

Risk stratification biomarkers for Staphylococcus aureus bacteraemia
por: Cao, Yi, et al.
Publicado: (2020)

Biomarkers for prostate cancer detection and risk stratification
por: Farha, Mark W., et al.
Publicado: (2022)

Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer
por: Boscolo, Alice, et al.
Publicado: (2020)

Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer
por: Manganaro, L., et al.
Publicado: (2023)

The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer
por: Middleton, G., et al.
Publicado: (2015)

Biomarkers of Acute Lung Injury The Individualized Approach: for Phenotyping, Risk Stratification and Treatment Surveillance
por: Murray, Daniel D., et al.
Publicado: (2019)

Risk Stratification for Lung Cancer Patients
por: Jain, Anchal, et al.
Publicado: (2022)

Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins
por: Monti, Marcello, et al.
Publicado: (2018)

A PET/CT volumetric parameter predicts prognosis of non-small cell lung cancer treated using preoperative chemoradiotherapy and surgery: A retrospective case series study
por: Katsui, Kuniaki, et al.
Publicado: (2021)

Improved risk stratification by PET-based intratumor heterogeneity in children with high-risk neuroblastoma
por: Li, Chao, et al.
Publicado: (2022)

PET/CT in the Staging of the Non-Small-Cell Lung Cancer
por: Chao, Fangfang, et al.
Publicado: (2012)

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

Volumetric hippocampal changes in glioblastoma: a biomarker for neuroplasticity?
por: Zilioli, Alessandro, et al.
Publicado: (2023)

Prognostic Value of Combing Primary Tumor and Nodal Glycolytic–Volumetric Parameters of (18)F-FDG PET in Patients with Non-Small Cell Lung Cancer and Regional Lymph Node Metastasis
por: Chen, Yu-Hung, et al.
Publicado: (2021)

Role of biomarkers in risk stratification of acute coronary syndrome
por: Nagesh, C.M., et al.
Publicado: (2010)

Biomarkers for Risk Stratification of Neoplastic Progression in Barrett Esophagus
por: Kerkhof, Marjon, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_gd6m83gbfj4i9eiab1ev54573k